Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.99
Delayed Data
As of Jul 01
 +0.485 / +1.90%
Today’s Change
23.85
Today|||52-Week Range
43.63
-39.25%
Year-to-Date
Anavex's Lead Candidate Gets Orphan Drug Status Yet Again
Jun 23 / Zacks.com - Paid Partner Content
Fate's (FATE) ProTmune Gets Fast Track Status, Stock Up
Jun 21 / Zacks.com - Paid Partner Content